公开(公告)号：WO2012009639A3

公开(公告)日：2012-04-26

申请号：PCT/US2011044191

申请日：2011-07-15

Applicant: ADVANCED TECH MATERIALS ,  BARNES JEFFREY ,  LIPPY STEVEN ,  ZHENG PENG ,  RAJARAM REKHA

Inventor： BARNES JEFFREY ,  LIPPY STEVEN ,  ZHENG PENG ,  RAJARAM REKHA

IPC: H01L21/302 ,  H01L21/28

CPC classification number: C11D11/0041 ,  C11D3/042 ,  G03F7/42 ,  H01L21/02063 ,  H01L21/02071

Abstract: Cleaning compositions and processes for cleaning post-plasma etch residue from a microelectronic device having said residue thereon. The composition achieves highly efficacious cleaning of the residue material, including titanium-containing, copper-containing, tungsten-containing, and/or cobalt-containing post-etch residue from the microelectronic device while simultaneously not damaging the interlevel dielectric, metal interconnect material, and/or capping layers also present thereon.

Abstract translation: 用于从其上具有所述残余物的微电子器件清洁后等离子体蚀刻残留物的清洁组合物和方法。 该组合物可实现对来自微电子器件的残余物质（包括含钛，含铜，含钨和/或含钴）蚀刻后残留物的高效清洁，同时不损坏层间电介质，金属互连材料， 和/或也存在于其上的封盖层。

公开(公告)号：WO2012009639A2

公开(公告)日：2012-01-19

申请号：PCT/US2011044191

申请日：2011-07-15

Applicant: ADVANCED TECH MATERIALS ,  BARNES JEFFREY ,  LIPPY STEVEN ,  ZHENG PENG ,  RAJARAM REKHA

Inventor： BARNES JEFFREY ,  LIPPY STEVEN ,  ZHENG PENG ,  RAJARAM REKHA

IPC: H01L21/302 ,  H01L21/28

CPC classification number: C11D11/0041 ,  C11D3/042 ,  G03F7/42 ,  H01L21/02063 ,  H01L21/02071

Abstract: Cleaning compositions and processes for cleaning post-plasma etch residue from a microelectronic device having said residue thereon. The composition achieves highly efficacious cleaning of the residue material, including titanium-containing, copper-containing, tungsten-containing, and/or cobalt-containing post-etch residue from the microelectronic device while simultaneously not damaging the interlevel dielectric, metal interconnect material, and/or capping layers also present thereon.

公开(公告)号：WO2007044492A2

公开(公告)日：2007-04-19

申请号：PCT/US2006/039058

申请日：2006-10-04

Applicant: OPTISCAN BIOMEDICAL CORPORATION ,  STERLING, Bernhard, B. ,  GABLE, Jennifer, H. ,  BRAIG, James, R. ,  WECHSLER, Mark ,  ZHENG, Peng ,  RULE, Peter ,  KEENAN, Richard

Inventor： STERLING, Bernhard, B. ,  GABLE, Jennifer, H. ,  BRAIG, James, R. ,  WECHSLER, Mark ,  ZHENG, Peng ,  RULE, Peter ,  KEENAN, Richard

IPC: A61B5/15 ,  A61M5/172

CPC classification number: A61B5/14546 ,  A61B5/145 ,  A61B5/14532 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150755 ,  A61B5/150862 ,  A61B5/153 ,  A61B5/155 ,  A61B5/157 ,  A61B5/4839 ,  A61M5/14212 ,  A61M2230/20 ,  G01N35/1095

Abstract: In certain embodiments, a method samples a body fluid of a patient. The method includes providing a fluid handling system having one or more fluid passageways. The method further includes infusing an infusion fluid by way of a fluid handling system into a patient through one or more fluid passageways. The method further includes obtaining a sample of body fluid by way of a fluid handling system from a patient through one or more fluid passageways. The obtained sample is no more than 5 milliliters in volume. The method further includes analyzing at least an analyzed portion of the obtained sample by way of an analyte detection system operatively associated with the fluid handling system to determine a concentration of at least one analyte.

Abstract translation: 在某些实施方案中，方法对患者的体液进行取样。 该方法包括提供具有一个或多个流体通道的流体处理系统。 该方法还包括通过流体处理系统通过一个或多个流体通道将输注流体输入患者体内。 该方法还包括通过来自患者的流体处理系统通过一个或多个流体通道获得体液样品。 所得样品的体积不超过5毫升。 该方法还包括通过可操作地与流体处理系统相关联的分析物检测系统分析所获得的样品的至少一部分分析物，以确定至少一种分析物的浓度。

公开(公告)号：WO2006088792A3

公开(公告)日：2007-03-01

申请号：PCT/US2006005027

申请日：2006-02-13

Applicant: OPTISCAN BIOMEDICAL CORP ,  STERLING BERNHARD B ,  HALL W DALE ,  CALLICOAT DAVID N ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  WITTE KENNETH G ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD ,  KING RICHARD A

Inventor： STERLING BERNHARD B ,  HALL W DALE ,  CALLICOAT DAVID N ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  WITTE KENNETH G ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD ,  KING RICHARD A

IPC: A61B5/15

CPC classification number: A61M5/1723 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/14557 ,  A61B5/1495 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150755 ,  A61B5/150862 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/155 ,  A61B5/157 ,  A61M5/14212 ,  A61M5/14232 ,  A61M5/16854 ,  A61M2205/12 ,  A61M2230/20 ,  A61M2230/201 ,  G01N1/14 ,  G01N21/05 ,  G01N21/274 ,  G01N21/35 ,  G01N2021/0346

Abstract: An apparatus (10) for analyzing the composition of bodily fluid. The apparatus comprises a fluid handling network including a patient end (11) configured to maintain fluid communication with a bodily fluid in a patient and at least one pump (203) intermittently operable to draw a sample of bodily fluid from the patient. The apparatus further comprises a fluid analyzer (140) positioned to analyze at least a portion of the sample and measure the presence of two or more analytes . Also disclosed is a method for analyzing the composition of a bodily fluid in a patient. The method comprises drawing a sample of the bodily fluid of the patient through a fluid handling network configured to maintain fluid communication with a bodily fluid in a patient. The method further comprises analyzing the at least a portion of the sample in a fluid analyzer to estimate the concentration of two or more analytes in the sample. Disclosed are further means for separating plasma and serum and a spectroscopic analyzer.

Abstract translation: 一种用于分析体液组成的装置（10）。 该装置包括流体处理网络，其包括被配置为保持与患者体内的体液的流体连通的患者端部（11），以及间歇地可操作以从患者抽取体液样本的至少一个泵（203）。 该装置还包括流体分析器（140），其定位成分析样品的至少一部分并测量两种或多种分析物的存在。 还公开了一种用于分析患者体液组成的方法。 该方法包括通过流体处理网络来绘制患者的体液样本，流体处理网络被配置为保持患者体内与体液的流体连通。 该方法还包括在流体分析仪中分析样品的至少一部分以估计样品中两种或多种分析物的浓度。 公开了用于分离血浆和血清和光谱分析仪的进一步手段。

公开(公告)号：WO2003045235A1

公开(公告)日：2003-06-05

申请号：PCT/US2002/037513

申请日：2002-11-21

Applicant: OPTISCAN BIOMEDICAL CORPORATION ,  ZHENG, Peng ,  GABLE, Jennifer, H. ,  HALL, Dale, W. ,  WITTE, Kenneth, G. ,  BRAIG, James, R.

Inventor： ZHENG, Peng ,  GABLE, Jennifer, H. ,  HALL, Dale, W. ,  WITTE, Kenneth, G. ,  BRAIG, James, R.

IPC: A61B5/00

CPC classification number: A61B5/14532 ,  A61B5/1455 ,  A61B5/1491

Abstract: A device and method for determining analyte concentrations within a material sample are provided. A modulating temperature gradient is induced in the sample and resultant, emitted infrared radiation is measured at selected analyte absorbance peaks and reference wavelengths. The modulating temperature gradient is controlled by a surface temperature modulation. A transfer function relating the surface temperature modulation to a modulation of the measured infrared radiation is provided. Phase and magnitude differences in the transfer function are detected. These phase and magnitude differences, having a relationship to analyte concentration, are measured, correlated and processed to determine analyte concentration in the material sample. A method for adjusting an analyte measurement is provided. The method provides a hydration correction process for calibration and correction whereby analyte concentrations within the material sample may be determined. The hydration correction process is particularly suitable for determining blood analyte concentrations within human tissue.

Abstract translation: 提供了用于确定材料样品中的分析物浓度的装置和方法。 在样品中诱导调制温度梯度，并在所选分析物的吸收峰和参考波长处测量发射的红外辐射。 调制温度梯度由表面温度调制控制。 提供了将表面温度调制与测量的红外辐射的调制相关联的传递函数。 检测传递函数的相位和幅度差异。 测量，相关和处理与分析物浓度有关的这些相位和幅度差异，以确定材料样品中的分析物浓度。 提供了一种用于调节分析物测量的方法。 该方法提供用于校准和校正的水合校正过程，从而可以确定材料样品中的分析物浓度。 水合校正过程特别适用于测定人体组织内的血液分析物浓度。

公开(公告)号：WO2012009639A9

公开(公告)日：2012-01-19

申请号：PCT/US2011/044191

申请日：2011-07-15

Applicant: ADVANCED TECHNOLOGY MATERIALS, INC. ,  BARNES, Jeffrey ,  LIPPY, Steven ,  ZHENG, Peng ,  RAJARAM, Rekha

Inventor： BARNES, Jeffrey ,  LIPPY, Steven ,  ZHENG, Peng ,  RAJARAM, Rekha

IPC: H01L21/302 ,  H01L21/28

Abstract: Cleaning compositions and processes for cleaning post-plasma etch residue from a microelectronic device having said residue thereon. The composition achieves highly efficacious cleaning of the residue material, including titanium-containing, copper-containing, tungsten-containing, and/or cobalt-containing post-etch residue from the microelectronic device while simultaneously not damaging the interlevel dielectric, metal interconnect material, and/or capping layers also present thereon.

公开(公告)号：WO2007044492A3

公开(公告)日：2007-07-26

申请号：PCT/US2006039058

申请日：2006-10-04

Applicant: OPTISCAN BIOMEDICAL CORP ,  STERLING BERNHARD B ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD

Inventor： STERLING BERNHARD B ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD

IPC: A61B5/15 ,  A61M5/172

CPC classification number: A61B5/14546 ,  A61B5/145 ,  A61B5/14532 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150755 ,  A61B5/150862 ,  A61B5/153 ,  A61B5/155 ,  A61B5/157 ,  A61B5/4839 ,  A61M5/14212 ,  A61M2230/20 ,  G01N35/1095

Abstract: Disclosed is a system that samples a body fluid of a patient. The system includes a fluid handling system (10) having one or more fluid passageways. The system further includes a pump system for infusing an infusion fluid by way of a fluid handling system into a patient (P) through one or more fluid passageways . The system further includes a pump system for obtaining a sample of body fluid by way of a fluid handling system from a patient through one or more fluid passageways. The obtained sample is no more than 5 milliliters in volume. The system further includes an analyzer (140) for analyzing at least an analyzed portion of the obtained sample by way of an analyte detection system operatively associated with the fluid handling system to determine a concentration of at least one analyte.

Abstract translation: 公开了一种对患者的体液进行采样的系统。 该系统包括具有一个或多个流体通道的流体处理系统（10）。 该系统还包括一个泵系统，用于通过流体处理系统将输液通过一个或多个流体通道输入患者（P）。 该系统还包括泵系统，用于通过来自患者的流体处理系统通过一个或多个流体通道获得体液样本。 所得样品的体积不超过5毫升。 该系统还包括分析器（140），用于通过可操作地与流体处理系统相关联的分析物检测系统来分析至少所获得的样品的分析部分，以确定至少一种分析物的浓度。

公开(公告)号：WO2006088772A1

公开(公告)日：2006-08-24

申请号：PCT/US2006/004933

申请日：2006-02-13

Applicant: OPTISCAN BIOMEDICAL CORPORATION ,  STERLING, Bernhard B. ,  GABLE, Jennifer H. ,  BRAIG, James R. ,  WECHSLER, Mark ,  ZHENG, Peng ,  RULE, Peter ,  KEENAN, Richard

Inventor： STERLING, Bernhard B. ,  GABLE, Jennifer H. ,  BRAIG, James R. ,  WECHSLER, Mark ,  ZHENG, Peng ,  RULE, Peter ,  KEENAN, Richard

IPC: A61B5/15 ,  A61M5/172

CPC classification number: A61B5/14546 ,  A61B5/145 ,  A61B5/14532 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150755 ,  A61B5/150862 ,  A61B5/153 ,  A61B5/155 ,  A61B5/157 ,  A61B5/4839 ,  A61M5/14212 ,  A61M2230/20 ,  G01N35/1095

Abstract: Described is a method of sampling a body fluid of a patient. The method includes providing a fluid handling system having one or more fluid passageways (20). The method further includes infusing an infusion fluid by way of a fluid handling system into a patient through one or more fluid passageways. The method further includes obtaining a sample of body fluid by way of a fluid handling system from a patient through one or more fluid passageways. The obtained sample is no more than 400 microliters in volume. The method further includes analyzing at least an analyzed portion of the obtained sample by way of an analyte detection system (324) operatively associated with the fluid handling system to determine a concentration of at least one analyte. A corresponding system is also disclosed.

Abstract translation: 描述了对患者的体液进行取样的方法。 该方法包括提供具有一个或多个流体通道（20）的流体处理系统。 该方法还包括通过流体处理系统通过一个或多个流体通道将输注流体输入患者体内。 该方法还包括通过来自患者的流体处理系统通过一个或多个流体通道获得体液样品。 所得样品的体积不超过400微升。 该方法还包括通过与流体处理系统可操作地相关联的分析物检测系统（324）分析所获得的样品的至少一部分分析物，以确定至少一种分析物的浓度。 还公开了相应的系统。

公开(公告)号：WO2003039362A1

公开(公告)日：2003-05-15

申请号：PCT/US2002/035707

申请日：2002-11-06

Applicant: OPTISCAN BIOMEDICAL CORPORATION ,  STERLING, Bernhard, B. ,  HARTSTEIN, Philip, C. ,  LI, Kenneth, I. ,  AGOSTINO, Mark, D. ,  KLONOFF, David, C. ,  GAFFNEY, Robert, D. ,  ZHENG, Peng ,  GABLE, Jennifer, H. ,  WITTE, Kenneth, G. ,  SMITH, Heidi, M. ,  SHEILL, Jane, J. ,  MUNROW, Mike, A. ,  HALL, W., Dale ,  GOLDBERGER, Daniel, S. ,  FENNELL, Martin, J. ,  CORTELLA, Julian, M. ,  BRAIG, James, R. ,  RULE, Peter

Inventor： STERLING, Bernhard, B. ,  HARTSTEIN, Philip, C. ,  LI, Kenneth, I. ,  AGOSTINO, Mark, D. ,  KLONOFF, David, C. ,  GAFFNEY, Robert, D. ,  ZHENG, Peng ,  GABLE, Jennifer, H. ,  WITTE, Kenneth, G. ,  SMITH, Heidi, M. ,  SHEILL, Jane, J. ,  MUNROW, Mike, A. ,  HALL, W., Dale ,  GOLDBERGER, Daniel, S. ,  FENNELL, Martin, J. ,  CORTELLA, Julian, M. ,  BRAIG, James, R. ,  RULE, Peter

IPC: A61B5/00

CPC classification number: A61B5/1455 ,  A61B5/01 ,  A61B5/14532 ,  A61B5/150022 ,  A61B5/150061 ,  A61B5/150213 ,  A61B5/150274 ,  A61B5/150358 ,  A61B5/150412 ,  A61B5/150458 ,  A61B5/150755 ,  A61B5/15087 ,  A61B5/151 ,  A61B5/157 ,  A61B5/6826 ,  A61B5/6838 ,  A61B2562/0295 ,  A61B2562/12 ,  G01N21/35

Abstract: A reagentless whole-blood analyte detection system (200, 400, 450, 1000, 1100) that is capable of being deployed near a patient has a source (220) capable of emitting a beam of radiation that includes a spectral band. The whole-blood system (200, 400, 450, 1000, 1100) also has at least one detector (250, 1152, 1154) in an optical path of the beam. The whole-blood system (200, 400, 450, 1000, 1100) also has a housing (402, 452) that is configured to house the source (220) and the detector(s) (250, 1152, 1154). The whole-blood system (200, 400, 450, 1000, 1100) also has a sample element (240, 305, 605, 805, 885, 905, 1040, 1205, 1305, 1355, 1405) that is situated in the optical path of the beam. The sample element (240, 305, 605, 805, 885, 905, 1040, 1205, 1305, 1355, 1405) has a sample cell (242, 310, 610, 810) and a sample cell wall (244, 330, 335) that does not eliminate transmittance of the beam of radiation in the spectral band.

Abstract translation: 能够在患者附近部署的无试剂全血分析物检测系统（200,400,450,1000,1100）具有能够发射包括光谱带的辐射束的源（220）。 全血系统（200,400,450,1000,1100）还具有在光束的光路中的至少一个检测器（250,1152,1154）。 全血系统（200,400,450,1000,1100）还具有构造成容纳源（220）和检测器（250,1152,1154）的壳体（402,452）。 全血系统（200,400,450,1000,1100）还具有位于光学系统中的样品元件（240,305,605,805,885,905,1040,1205,1305,135,1405） 梁的路径。 样品元件（240,305,605,805,885,905,1040,1205,1305,135,1405）具有样品池（242,310,610,810）和样品池壁（244,330,335） ），其不消除光谱带中的辐射束的透射率。

公开(公告)号：WO2006091426A3

公开(公告)日：2007-04-19

申请号：PCT/US2006005112

申请日：2006-02-13

Applicant: OPTISCAN BIOMEDICAL CORP ,  CALLICOAT DAVID N ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  LI KENNETH I ,  WITTE KENNETH G ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD ,  KING RICHARD A

Inventor： CALLICOAT DAVID N ,  GABLE JENNIFER H ,  BRAIG JAMES R ,  LI KENNETH I ,  WITTE KENNETH G ,  WECHSLER MARK ,  ZHENG PENG ,  RULE PETER ,  KEENAN RICHARD ,  KING RICHARD A

IPC: A61B5/15 ,  A61M5/172

CPC classification number: A61B5/157 ,  A61B5/0071 ,  A61B5/0075 ,  A61B5/0084 ,  A61B5/0086 ,  A61B5/1411 ,  A61B5/1427 ,  A61B5/1451 ,  A61B5/14517 ,  A61B5/14532 ,  A61B5/14535 ,  A61B5/14546 ,  A61B5/1455 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150267 ,  A61B5/150358 ,  A61B5/150755 ,  A61B5/150862 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/155 ,  A61B5/4839 ,  A61B10/0064 ,  A61B2560/0443 ,  A61M5/14212 ,  A61M5/14232 ,  A61M5/16854 ,  A61M5/1723 ,  A61M5/365 ,  A61M5/38 ,  A61M2205/12 ,  A61M2205/3306 ,  A61M2230/20 ,  A61M2230/201 ,  G01N21/03 ,  G01N21/3577 ,  G01N2021/3595 ,  G01N2201/02 ,  G01N2201/061 ,  Y10T137/4478 ,  Y10T137/7722 ,  Y10T137/86485 ,  Y10T436/111666 ,  Y10T436/2575

Abstract: A method of extracting and analyzing bodily fluids from a patient at the point of care for the patient is provided. The method comprises establishing fluid communication between an analyte detection system 334, 1700 and a bodily fluid in the patient. A portion of the bodily fluid is drawn from the patient. The drawn portion is separated into a first component of the bodily fluid, while the analyte detection system 334, 1700 remains in fluid communication with the patient. The analyte detection system 334, 1700 analyzes the first component to measure a concentration of an analyte.

Abstract translation: 提供了在患者护理点从患者提取和分析体液的方法。 该方法包括建立分析物检测系统334,1700与患者体液之间的流体连通。 体液的一部分从患者身上抽出。 被拉伸的部分被分离成体液的第一组分，而分析物检测系统334,1700与患者保持流体连通。 分析物检测系统334,1700分析第一组分以测量分析物的浓度。